Cantor Fitzgerald Reiterates Overweight on Tango Therapeuticsto Overweight

Benzinga12/05 21:37

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Businesswire12/03 20:00

Tango Therapeutics Granted FDA Orphan Designation Status For "Small Molecule Inhibitor of PRMT5 (Protein Arginine Methyl Transferase 5)" Treatment Of Pancreatic Cancer

Benzinga11/27 22:59

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Businesswire11/27 20:00

Tango Therapeutics Inc. (TNGX): Among the Most Promising Cancer Stocks According to Hedge Funds

Yahoo Finance11/23 23:26

Versant Ventures Unveils Pep2Tango Therapeutics Inc.

Businesswire11/21 21:00